NIMBUS Biotechnology: Change to Business Board
Advertisement
NIMBUS biotechnology reported a change to the company's Supervisory Board. Professor Axel Kleemann, formerly executive board member of Asta Medica AG has been appointed as a new member and chairman of the Supervisory Board. Professor Thomas Bayerl, Dr. Rainer Strohmenger (Wellington Partners Venture Capital GmbH, Germany), Jack Griffin and Mario Ober (CFH, Germany) continue to be board members. Nimbus Biotechnology thanks Werner Zöllner (Seed GmbH, Germany) for his former work and support in this position.